Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform

Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”) and Genomic Testing Cooperative, LCA (“GTC”) today announced a collaboration to integrate GTC’s next-generation sequencing (NGS) ...

Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring

Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), today highlighted the recent update to the National Comprehensive Cancer Network ® (NCCN ®) Clinical Practice Guidelines in Oncology ...
Business Wire

Introducing AttackIQ's NIST CSF Automated Assessments

SANTA CLARA, Calif.--(BUSINESS WIRE)--AttackIQ®, the leading independent vendor of breach and attack simulation solutions and a founding research partner of the MITRE Engenuity Center for ...
Fierce Healthcare

HITRUST CSF Assurance Program Continues to be the Most Widely Used Security Assessment Approach in the Healthcare Industry

FRISCO, Texas--(BUSINESS WIRE)-- The Health Information Trust Alliance (HITRUST) announced today that the HITRUST CSF Assurance Program, based on the HITRUST Common Security Framework (CSF), continues ...
Business Wire

HITRUST® Releases Version 9.4 of the HITRUST CSF® Incorporating the DoD CMMC, and Approach to Community Standards

FRISCO, Texas--(BUSINESS WIRE)--HITRUST, a leading data protection standards development and certification organization, today announced the availability of version 9.4 of the HITRUST CSF information ...
Fierce Healthcare

Healthcare Industry Leaders Collaborate to Streamline Third Party Assessment Process

The Health Information Trust Alliance (HITRUST) is announcing today that leading healthcare organizations will be requiring their business associates to participate in the HITRUST Common Security ...